Abstract
Menorrhagia is a symptom denoting excessively heavy menstrual bleed ing. It is a complaint that is
difficult to verify objectively in many cases, even with a detailed case history. Issues of perception and
tolerance of symptoms are important in whether a patient presents to a doctor, and this varies
considerably from one society to another. Research studies indicate tha t the upper limit of normal
blood loss is between 60 and 80 ml/month. Above this level women tend to become progressively iron
deficient. Hence, any development which may help the precision of this assessment is valuable, and
several of these will be discussed. Causes of menorrhagia can be div ided into three groups: (1) pelvic
diseases, such as myomata and adenomyosis; (2) systemic disorders, such a s coagulopathies and
hypothyroidism; and (3) dysfunctional uterine bleeding —a diagnosis of exclusion. Investigations are
mainly aimed at improving the precision of the underlying diagnosis, de fining the severity of the
condition and excluding anaemia. Hence, the most important investig ations are a full blood count, a
diagnostic hysteroscopy and endometrial sampling. In clinical practice, other specific investigations
need only be carried out if there are unusual features in the history or examination, or if previous
treatments have failed. In a research situation there have been numerous studies aimed at elucidation of
the mechanisms of heavy bleeding and some of these will be reviewed.
Keywords
myomata, adenomyosis, coagulopathies, hypothyroidism, dysfunctional uterine bleeding
Introduction
Menorrhagia is defined as heavy but regular menstrual bleeding. Idiopathic ovulatory
menorrhagia is regular heavy bleeding in the absence of recognisable p elvic pathology or a
general bleeding disorder. Objective menorrhagia is taken to be a total men strual blood loss
of 80 mL or more in each menstruation. Subjectively, menorrhagia m ay be defined as a
complaint of regular excessive menstrual blood loss occurring over several consecutive
cycles in a woman of reproductive age.
Incidence/Prevalence
In the UK, 5% of women aged 30-49 years consult their general pr actitioners each year with
menorrhagia. In New Zealand, 2-4% of primary-care consultations by pr emenopausal
women are for menstrual problems.
Aetiology/Risk factors
Idiopathic ovulatory menorrhagia is thought to be caused by disordered prostaglandin
production within the endometrium. Prostaglandins may also be implica ted in menorrhagia
associated with uterine fibroids, adenomyosis, or the presence of an IUD. Fibroids have been
reported in 10% of women with menorrhagia (80-100 mL/cycle), and i n 40% of women with
severe menorrhagia (at least 200 mL/cycle).
Prognosis
Menorrhagia limits normal activities and causes iron-deficiency anaemia in t wo thirds of
women proven to have objective menorrhagia. One in five women in the UK and one in
three in the USA have a hysterectomy before the age of 60 years; meno rrhagia is the main
presenting problem in at least half of these women. About half of wom en who have a
hysterectomy for menorrhagia are found to have an anatomically normal uterus.
International Journal of Homoeopathic Sciences http://www.homoeopathicjournal.com
~ 299 ~
Aims of intervention
To reduce menstrual bleeding; improve quality of life; and
prevent or correct iron-deficiency anaemia, with minimum
adverse effects. Women may regard amenorrhea as a benefit
or a harm of treatment, depending on their perspective.
Outcomes
Menstrual blood flow (assessed objectively [mL/cycle] or
subjectively); haemoglobin concentration; quality of life;
patient satisfaction; incidence of adverse drug effects; and
incidence of postoperative complications. Whether a
particular percentage reduction in menstrual blood loss is
considered clinically important will depend on pre-treatment
menstrual loss and on individual women's perceptions of
acceptable menstrual loss.
Disclaimer
The information contained in this publication is intended for
medical professionals. Categories presented in Clinical
Evidence indicate a judgement about the strength of the
evidence available to our contributors prior to publication
and the relevant importance of benefit and harms. We rely
on our contributors to confirm the accuracy of the
information presented and to adhere to describe accepted
practices. Readers should be aware that professionals in the
field may have different opinions. Because of this and
regular advances in medical research we strongly
recommend that readers' independently verify specified
treatments and drugs including manufacturers' guidance.
Also, the categories do not indicate whether a particular
treatment is generally appropriate or whether it is suitable
for a particular individual. Ultimately it is the readers'
responsibility to make their own professional judgements,
so to appropriately advise and treat their patients. To the
fullest extent permitted by law, BMJ Publishing Group
Limited and its editors are not responsible for any losses,
injury or damage caused to any person or property
(including under contract, by negligence, products liability
or otherwise) whether they be direct or indirect, special,
incidental or consequential, resulting from the application of
the information in this publication.
Homeopathic approach
Bovista
Premenstrual problems with puffiness in the extremities,
fluid retention, and a bloated feeling often indicate a need
for this remedy. The woman may feel very awkward and
clumsy, and may constantly be dropping things because of
swollen-feeling hands. Diarrhea occurring around the time
of the menstrual period strongly indicates this remedy.
Calcarea carbonica
PMS with fatigue, anxiety, and a feeling of being
overwhelmed suggest a need for this remedy. The woman
may have problems with water-retention and weight gain,
tender breasts, digestive upsets, and headaches. Periods
often come too early and last too long, sometimes with a
flow of bright red blood. A general feeling of chilliness,
with clammy hands and feet, and cravings for sweets and
eggs are other indications for Calcarea.
Lachesis
Women who need this remedy are usually intense, with a
tremendous need for an outlet, both physically and mentally.
Symptoms of PMS include congestion, headaches, flushing,
surges of heat, and an intense outspoken irritability —often
with strong feelings of suspicion or jealousy. When the flow
arrives, it may be heavy, but brings relief of tension.
Intolerance of restrictive clothing around the waist or neck
is another indication for Lachesis.
Lycopodium
PMS with a craving for sweets and a ravenous appetite
(sometimes a bulimic tendency) suggests a need for this
remedy. Digestive upsets with abdominal bloating and
flatulence are often seen, with the person feeling worst in
the late afternoon and evening. Menstrual periods may be
delayed, followed by a heavy flow that goes on for extra
days. A woman who needs this remedy often wears a
worried look and lacks self-confidence —although she may
be irritable and bossy to pets and family members. A desire
to be alone, but with someone in the other room, is another
indication for Lycopodium.
Natrummuriaticum
A person who needs this remedy usually seems reserved to
others, but is deeply emotional inside. She may feel
extremely sad and lonely, but gets affronted or angry if
others try to console her or sympathize. Depression, anger
over minor things, and a need to be alone to cry are often
seen when Natrummur is needed. Menstrual problems can
be accompanied by migraines, or a backache that feels
better from lying on something hard or pushing a solid
object against the painful place. A craving for salt, strong
thirst, and a tendency to feel worse from being in the sun are
other indications for this remedy.
Nux vomica
When a woman with PMS is extremely impatient, pushy,
and intolerant, this remedy may be of use. Uncomfortable,
irregular menstrual periods can be experienced, often with a
nagging urge to move the bowels before the flow begins.
Constipation is common, and constricting pains may extend
to the rectum or tailbone region. Anger, mental strain,
physical exertion, and overindulgence in coffee, alcohol, or
food can aggravate the problems. The woman often feels
chilly and improves from warmth and rest.
References
1. Hallberg L, Hogdahl A, Nilsson L et al . Menstrual
blood loss – a population study: variation at different
ages and attempts to define normality. Acta Obstet
Gynecol Scand 1966;45:320-351.
2. Vessey MP, Villard-Mackintosh L, McPherson K et al.
The epidemiology of hysterectomy: findings in a large
cohort study. Br J Obstet Gynaecol 1992;99:402-407.
3. Working Party of the National Health Committee New
Zealand. Guidelines for the management of heavy
menstrual bleeding. Wellington: Ministry of Health,
(Available from The Ministry of Health, 133
Molesworth Street, PO Box 5013, Wellington, New
Zealand). Search date 1996; primary sources Medline,
Embase, Current Contents, Biological Abstracts, Social
Sciences Index, Psychlit, and Cinahl 1998.
4. Smith SK, Abel MH, Kelly RW et al . A role for
prostacyclin (PGI 2) in excessive menstrual
bleeding. Lancet 1981;1:522-524.
5. Rybo G, Leman J, Tibblin R. Epidemiology of
International Journal of Homoeopathic Sciences http://www.homoeopathicjournal.com
~ 300 ~
menstrual blood loss. In: Baird DT, Michie EA,
eds. Mechanisms of menstrual bleeding. New York:
Raven Press 1985, P181-193.
6. Alexander DA, Naji AA, Pinion SB et al. Randomised
trial comparing hysterectomy with endometrial ablation
for dysfunctional uterine bleeding: psychiatric and
psychosocial aspects. BMJ 1996;312:280-284.
7. Mansfield PK, Voda A, Allison G. Validating a pencil-
and-paper measure of perimenopausal menstrual blood
loss. Women’s health issues 2004;14:242-7.
8. Ferri FF. Ferri’s clinical advisor: instant diagnosis and
treatment. Philadelphia: Elsevier Mosby 2006, P207.
9. Albers JR, Hull SK, Wesley RM. Abnormal uterine
bleeding. Am Fam Physician 2004;69:1915-26.
10. Goldstein SR. Menorrhagia and abnormal bleeding
before the menopause. Best Pract Res Clin Obstet
Gynaecol 2004;18:59-69.
11. Christensen MG. National Board of Chiropractic
Examiners. Job analysis of chiropractic: A project
report, survey analysis, and summary of the practice of
chiropractic within the United States. Greeley, CO:
National Board of Chiropractic Examiners 2005.
12. Survey of Women Who Experience Heavy Menstrual
Bleeding [Internet]; National Women’s Health
Resource Center 2005.
http://www.healthywomen.org/presskit/NWHRCsurvey
EMB2005.pdf.
13. Shapley M, Jordan K, Croft PR. Why women consult
with increased vaginal bleeding: A case-control
study. Br J Gen Pract 2002;52:108-13.
14. Shaw JA, Menorrhagia Shaw H.
2005. http://www.emedicine.com/medtopic1449htm.
15. Duckitt K, McCully K. Menorrhagia. ClinEvid 2004,
P2639-63.
16. Dysfunctional Uterine Bleeding 2006.
http://my.webmd.com/hw/abnormal_uterine_bleeding//
a79068/asp?printing+true.
17. Rakel RE, Bope ET, Conn HF. Conn’s current therapy:
latest approved methods of treatment for the practicing
physician. Philadelphia, Pa.: London. Current, therapy
2005.
18. Beers MH, Fletcher AJ. 2nd home, [all new &
completely rev.] ed. Merck Research Laboratories. The
Merck manual of medical information 2003.
19. Dambro MR. Griffith’s 5 -minute clinical
consult. Philadelphia, PA: Lippincott Williams &
Wilkins 2005, P696.
20. Danforth DN, Scott JR. In: Danforth’s obstetrics and
gynecology. 9. Scott James R et al ., editors.
Philadelphia: Lippincott Williams & Wilkins 2003.
21. Engstrom JL, Rose R, Brill AI, Polhill KM, Lukanich
CM, Fritz L. Adi BS. Efficacy of homoeopathic
medicines in chronic low back pain: a clinical study.
International Journal of Alternative and
Complementary Medicine 2020, 17-20. Midwifery care
of the woman with menorrhagia. J Nurse
Midwifery 1999;44:89-105.
22. Pizzorno JE, Murray MT. Textbook of natural
medicine. 3. St. Louis, Mo.: Churchill Livingstone
Elsevier 2006, P1901-1906.
23. Venes D, Taber CW. In: Taber’s cyclopedic medical
dictionary. Ed. 20, illustrated in full color/editor. Venes
Donald, et al ., editors. Philadelphia: F.A. Davis Co
2005.
24. Siegel JE. Abnormalities of hemostasis and abnormal
uterine bleeding. Clin Obstet Gynecol 2005;48:284-94.
25. DeCherney AH, Nathan L. In: Current obstetric &
gynecologic diagnosis & treatment. 9th,
international/DeCherney Alan H, Nathan Lauren.,
editors. New York: Lange Medical Books/McGraw-Hill
2003, P626-627.
26. Kabalak AA, Soyal OB, Urfalioglu A, Saracoglu F,
Gogus N. Menometrorrhagia and tachyarrhythmia after
using oral and topical ginseng. Ganganagar S. A
clinical study of amoebic dysentery and its
homoeopathic management. IOSR J Pharm Biol Sci
2017;12(1):98-102. J Womens Health
(Larchmt) 2004;13:830-3.
27. Speroff L, Fritz MA. Clinical gynecologic
endocrinology and infertility. 7. Philadelphia:
Lippincott Williams & Wilkins 2005.
28. Janssen CA, Scholten PC, Heintz AP. Reconsidering
menorrhagia in gynecological practice: is a 30-year-old
definition still valid? Eur J Obstet Gynecol Reprod
Biol 1998;78:69-72.
29. Milman N, Clausen J, Byg KE. Iron status in 268
Danish women aged 18 –30 years: Influence of
menstruation, contraceptive method, and iron
supplementation. Ann Hematol 1998;77:13-19.
30. Papadakis MA, McPhee SJ. Current consult
medicine. New York: Lange Medical/McGraw-Hill
Professional 2005.
31. Oehler MK, Rees MC. Menorrhagia: An update. Acta
Obstet Gynaecol Scand 2003;82:405-22.
32. Robins JC. Therapies for the treatment of abnormal
uterine bleeding. Curr Womens Health
Rep 2001;1:196-201.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.